次世代定序服務市場規模、佔有率、成長分析、按類型、按技術、按工作流程、按最終用途、按應用、按地區 - 行業預測，2025-2032 年

2023年全球次世代定序服務市場規模預計為84億美元，從2024年的102.8億美元成長到2032年的51.8億美元，預計預測期間（2025-2032年）年複合成長率為22.4%。至十億美元。

次世代定序(NGS)，也稱為大規模並行定定序，透過實現快速、高通量 DNA定序正在為生物技術、醫學診斷和病毒學等領域帶來革命性的變化。與傳統桑格方法相比，該技術顯著減少了序列測定所需的時間，從而增強了臨床和應用研究。 NGS 促進了關鍵的 DNA 預測序步驟並簡化了樣品製備和分析。隨著臨床實驗室的應用不斷成長，NGS 能夠在藥物基因組學中實現更快的疾病診斷和更有效的藥物發現。透過識別用於早期檢測的生物標記並實現個人化治療策略，NGS 正在促進向精準醫療的轉變，儘管是一個相對較新的市場，但分子生物學和遺傳學已展現出變革性的影響。

目錄

介紹

• 研究目的
• 調查範圍
• 定義

調查方法

• 資訊採購
• 二手資料和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 抑制因素和挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 價格分析

次世代定序服務市場規模：按類型

• 市場概況
• 人類基因組序列
• 單細胞定序
• 基於微生物基因組的序列分析
• 基因控制服務
  • 小RNA定序
  • 晶片序列
  • 其他基於基因調控的服務
• 動植物序列分析
• 其他定序服務

次世代定序服務市場規模：依技術分類

• 市場概況
• 合成定定序
• 離子半導體定序
• 奈米孔定序
• 單分子即時定序
• 其他技術

次世代定序服務市場規模：依工作流程分類

• 市場概況
• 前序
• 定序
• 資料分析

次世代定序服務市場規模：依最終用途分類

• 市場概況
• 大學及其他研究機構
• 醫院/診所
• 製藥和生物技術公司
• 其他

次世代定序服務市場規模：依應用分類

• 市場概況
• 診斷
• 腫瘤學
• 生殖健康
• 感染疾病
• 罕見遺傳疾病
• 其他
• 藥物發現
• 生物標記發現
• 微生物遺傳學農業動物研究
• 其他用途

次世代定序服務市場規模

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東/非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲

競爭資訊

• 前5名企業對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分類的佔有率分析
  • 收益與前一年同期比較（2022-2024）

主要企業簡介

• Illumina, Inc.（USA）
• Thermo Fisher Scientific Inc.（USA）
• BGI Genomics Co., Ltd.（China）
• Eurofins Scientific SE（Luxembourg）
• QIAGEN NV（Netherlands）
• Agilent Technologies, Inc.（USA）
• PerkinElmer, Inc.（USA）
• Macrogen, Inc.（South Korea）
• Pacific Biosciences of California, Inc.（USA）
• Oxford Nanopore Technologies plc（UK）
• Novogene Co., Ltd.（China）
• Psomagen, Inc.（USA）
• 10x Genomics, Inc.（USA）
• Takara Bio Inc.（Japan）
• Zymo Research Corp.（USA）
• CD Genomics（USA）
• MedGenome Labs Pvt Ltd.（India）
• Fulgent Genetics, Inc.（USA）
• Personalis, Inc.（USA）

結論和建議

Global Next-Generation Sequencing Services Market size was valued at USD 8.4 billion in 2023 and is poised to grow from USD 10.28 billion in 2024 to USD 51.80 billion by 2032, growing at a CAGR of 22.4% during the forecast period (2025-2032).

Next-generation sequencing (NGS), also known as massively parallel sequencing, revolutionizes fields such as biotechnology, medical diagnostics, and virology by enabling rapid and high-throughput DNA sequencing. This technology significantly reduces the time required to sequence a complete human genome compared to traditional Sanger methods, enhancing clinical and applied research. NGS facilitates crucial DNA pre-sequencing steps, enabling streamlined sample preparation and analysis. Its growing application in clinical laboratories allows for quicker illness diagnosis and more efficient drug discovery in pharmacogenomics. By identifying biomarkers for early detection and enabling personalized treatment strategies, NGS catalyzes the shift towards precision medicine, demonstrating its transformative impact on molecular biology and genetics despite being relatively new to the market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Next-Generation Sequencing Services market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Next-Generation Sequencing Services Market Segmental Analysis

Global Next-Generation Sequencing Services Market is segmented by type, technology, workflow, end use, application and region. Based on type, the market is segmented into human genome sequencing, single cell sequencing, microbial genome-based sequencing, gene regulation services, animal & plant sequencing and other sequencing services. Based on technology, the market is segmented into sequencing by synthesis, ion semiconductor sequencing, nanopore sequencing, single-molecule real-time sequencing and other technologies. Based on workflow, the market is segmented into pre-sequencing, sequencing and data analysis. Based on end use, the market is segmented into universities & other research entities, hospitals & clinics, pharma & biotech entities and others. Based on application, the market is segmented into diagnostics, oncology, reproductive health, infectious diseases, rare genetic disorders, others, drug discovery, biomarker discovery, microbial genetics, agriculture, and animal research and other applications. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Next-Generation Sequencing Services Market

The global Next-Generation Sequencing (NGS) services market is experiencing significant growth, primarily driven by advancements in clinical diagnostics across various fields, including forensics, reproductive health, and personalized medicine. NGS has emerged as the industry benchmark in clinical laboratories for diagnosing genetic disorders due to its analytical precision, high throughput capabilities, and cost-effectiveness. As the technology becomes more affordable, NGS is increasingly accessible, facilitating the diagnosis and treatment of rare diseases through genomic approaches. Additionally, the expansion of library preparation options and the growing pool of trained personnel are further propelling market growth, while ongoing improvements in sequencing technologies pave the way for novel therapies targeting Mendelian disorders and cancer.

Restraints in the Global Next-Generation Sequencing Services Market

The Global Next-Generation Sequencing (NGS) Services market faces several restraints, primarily stemming from legal and ethical challenges associated with DNA sequencing. These concerns encompass issues such as identifiability, the release of research findings, potential stereotyping, the adequacy of consent, stigma, inclusion, and unequal benefits among different groups. Such ethical considerations significantly hinder market growth. Additionally, the challenges of establishing in-house high-throughput devices and interpreting the complex data generated by NGS platforms are critical factors that are anticipated to further impede market expansion in the upcoming years, creating a cautious atmosphere among stakeholders in the industry.

Market Trends of the Global Next-Generation Sequencing Services Market

The Global Next-Generation Sequencing (NGS) Services market is witnessing a significant shift towards advanced technologies such as third-generation sequencing, which bypass traditional clonal amplification and polymerase chain reaction (PCR) methodologies. Innovations in single-molecule sequencing and real-time sequencing offer advantages, including longer read lengths and simplified preparatory processes, which reduce the risk of PCR-related errors. Platforms like Single-Molecule Real-Time (SMRT) sequencing and the FRET Sequencing platform are gaining traction due to their high accuracy and efficiency, propelling the market forward. The growing demand for precision medicine, genomics research, and personalized healthcare is further driving the adoption of these next-gen solutions, positioning NGS services as a pivotal market trend.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Next-Generation Sequencing Services Market Size by Type & CAGR (2025-2032)

• Market Overview
• Human Genome Sequencing
• Single Cell Sequencing
• Microbial Genome-Based Sequencing
• Gene Regulation Services
  • Small RNA Sequencing
  • Chip Sequencing
  • Other Gene Regulation-Based Services
• Animal & Plant Sequencing
• Other Sequencing Services

Global Next-Generation Sequencing Services Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Sequencing By Synthesis
• Ion Semiconductor Sequencing
• Nanopore Sequencing
• Single-Molecule Real-Time Sequencing
• Other Technologies

Global Next-Generation Sequencing Services Market Size by Workflow & CAGR (2025-2032)

• Market Overview
• Pre-Sequencing
• Sequencing
• Data Analysis

Global Next-Generation Sequencing Services Market Size by End Use & CAGR (2025-2032)

• Market Overview
• Universities & Other Research Entities
• Hospitals & Clinics
• Pharma & Biotech Entities
• Others

Global Next-Generation Sequencing Services Market Size by Application & CAGR (2025-2032)

• Market Overview
• Diagnostics
• Oncology
• Reproductive Health
• Infectious Diseases
• Rare Genetic Disorders
• Others
• Drug Discovery
• Biomarker Discovery
• Microbial Genetics, Agriculture, And Animal Research
• Other Applications

Global Next-Generation Sequencing Services Market Size & CAGR (2025-2032)

• North America (Type, Technology, Workflow, End Use, Application)
  • US
  • Canada
• Europe (Type, Technology, Workflow, End Use, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Technology, Workflow, End Use, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Technology, Workflow, End Use, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Technology, Workflow, End Use, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Illumina, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BGI Genomics Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific SE (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Macrogen, Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pacific Biosciences of California, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oxford Nanopore Technologies plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novogene Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Psomagen, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 10x Genomics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zymo Research Corp. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CD Genomics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MedGenome Labs Pvt Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fulgent Genetics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Personalis, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations